Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Taipei
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

PharmaEngine Inc

+ Add to Watchlist

4162:TT

252.00 TWD 6.50 2.65%

As of 02:31:46 ET on 05/22/2015.

Snapshot for PharmaEngine Inc (4162)

Open: 253.50 Day's Range: 251.00 - 255.00 Volume: 971,903
Previous Close: 245.50 52wk Range: 180.00 - 355.00 1-Yr Rtn: -23.64%

Stock Chart for 4162

No chart data available.
  • 4162:TT 252.00
  • 1D
  • 1M
  • 1Y
245.50
Interactive 4162 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4162

Current P/E Ratio (ttm) 249.7693
Estimated P/E(12/2015) 16.1538
Relative P/E vs. TWOTCI 9.6037
Earnings Per Share (TWD) (ttm) 1.0089
Est. EPS (TWD) (12/2015) 15.6000
Est. PEG Ratio -
Market Cap (M TWD) 25,658.89
Shares Outstanding (M) 101.82
30 Day Average Volume 900,922
Price/Book (mrq) 8.8483
Price/Sale (ttm) 109.6430
Dividend Indicated Gross Yield 0.40%
Cash Dividend (TWD) 1.0008
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4162

  • Revenue
  • Net Income (M/TWD)
  • Profit Margin (%)

Company Profile & Key Executives for 4162

PharmaEngine, Inc. operates as a biopharmaceutical company. The Company focuses on the development of new drugs for the treatment of cancer and Asian prevalent diseases.

Lin Jung-ChinChairmanGrace C YehPresident/CEO
Chang Chi-HsingVice President:Financial
More Company Profile & Key Executives for 4162

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil